Lantern Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BIOS CAPITAL MANAGEMENT, LP | 02/18/2025 | 1.21 M | $3.85 M | 100.00% | 11.22% |
| VANGUARD GROUP INC | 02/11/2025 | 363,720 | $1.16 M | 0.00% | 3.38% |
| CM MANAGEMENT, LLC | 02/07/2025 | 200,000 | $638,000 | 8.11% | 1.86% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 87,300 | $278,487 | 3.93% | 0.81% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 86,973 | $277,521 | -0.53% | 0.81% |
| NEWEDGE ADVISORS, LLC | 02/13/2025 | 68,359 | $218,074 | -50.23% | 0.64% |
| VOSS CAPITAL, LLC | 02/13/2025 | 50,000 | $159,500 | 100.00% | 0.46% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 40,596 | $129,501 | 0.29% | 0.38% |
| REDMOND ASSET MANAGEMENT, LLC | 02/03/2025 | 37,270 | $118,891 | -4.24% | 0.35% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 36,549 | $116,592 | -2.66% | 0.34% |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 01/17/2025 | 30,650 | $97,776 | 0.00% | 0.28% |
| HORIZON KINETICS ASSET MANAGEMENT LLC | 02/10/2025 | 28,791 | $91,843 | 4.38% | 0.27% |
| SIGMA PLANNING CORP | 02/03/2025 | 28,450 | $90,756 | -0.70% | 0.26% |
| UBS GROUP AG | 02/14/2025 | 27,684 | $88,312 | 3.03% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 26,482 | $84,478 | 0.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 26,301 | $83,900 | 20.20% | 0.24% |
| DAVENPORT & CO LLC | 01/24/2025 | 25,814 | $82,347 | -52.03% | 0.24% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 16,545 | $52,779 | -51.82% | 0.15% |
| PERIGON WEALTH MANAGEMENT, LLC | 01/22/2025 | 14,600 | $52,560 | -49.48% | 0.14% |
| 01/31/2025 | 10,000 | $48,100 | 100.00% | 0.09% | |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 4,608 | $14,699 | -42.46% | 0.04% |
| 02/06/2025 | 2,108 | $6,725 | 100.00% | 0.02% | |
| 02/10/2025 | 2,000 | $6,380 | 100.00% | 0.02% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 1,263 | $4,029 | -16.63% | 0.01% |
| RICHARDS, MERRILL & PETERSON, INC. | 02/13/2025 | 975 | $3,110 | 100.00% | 0.01% |
| PARKSIDE FINANCIAL BANK & TRUST | 02/05/2025 | 260 | $830 | 0.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 100 | $448 | 0.00% | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| AVANTAX PLANNING PARTNERS, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| INDIANA TRUST & INVESTMENT MANAGEMENT CO | 01/29/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| WOLFF WIESE MAGANA LLC | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lantern Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of Lantern Pharma Inc.. The most heavily invested institutionals were:
BIOS Capital Management, LP: 1.21 M
VANGUARD GROUP INC: 363,720
CM Management, LLC: 200,000
RENAISSANCE TECHNOLOGIES LLC: 87,300
GEODE CAPITAL MANAGEMENT, LLC: 86,973
NewEdge Advisors, LLC: 68,359
23.23% of Lantern Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.47 M shares in the last 24 months. This purchase volume represents approximately $10.34 M in transactions.